DocGo Target of Unusually Large Options Trading (NASDAQ:DCGO)

DocGo Inc. (NASDAQ:DCGO) was the recipient of some unusual options trading activity on Thursday. Traders acquired 7,426 put options on the stock. This is an increase of approximately 1,020% compared to the average daily volume of 663 put options.

Insider Activity

In related news, Director Michael J. Burdiek purchased 10,000 shares of the firm’s stock in a transaction dated Thursday, March 14th. The stock was purchased at an average price of $3.61 per share, with a total value of $36,100.00. Following the completion of the purchase, the director now owns 571,595 shares of the company’s stock, valued at approximately $2,063,457.95. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 13.78% of the company’s stock.

Institutional Investors Weigh In On DocGo

Hedge funds have recently modified their holdings of the company. Federated Hermes Inc. acquired a new position in shares of DocGo during the 3rd quarter worth about $29,000. Royal Bank of Canada raised its position in shares of DocGo by 226.3% during the 1st quarter. Royal Bank of Canada now owns 3,263 shares of the company’s stock worth $30,000 after purchasing an additional 2,263 shares during the last quarter. AJOVista LLC acquired a new position in shares of DocGo during the 4th quarter worth about $25,000. Tower Research Capital LLC TRC raised its position in shares of DocGo by 145.6% during the 3rd quarter. Tower Research Capital LLC TRC now owns 5,908 shares of the company’s stock worth $31,000 after purchasing an additional 3,502 shares during the last quarter. Finally, Wells Fargo & Company MN raised its position in shares of DocGo by 320.1% during the 4th quarter. Wells Fargo & Company MN now owns 6,192 shares of the company’s stock worth $44,000 after purchasing an additional 4,718 shares during the last quarter. 56.44% of the stock is owned by hedge funds and other institutional investors.

DocGo Price Performance

Shares of DCGO opened at $3.57 on Friday. The firm has a market capitalization of $371.89 million, a PE ratio of 51.00, a price-to-earnings-growth ratio of 0.34 and a beta of 0.91. DocGo has a 1-year low of $2.78 and a 1-year high of $10.82. The company’s fifty day moving average price is $3.73 and its 200-day moving average price is $4.64.

DocGo (NASDAQ:DCGO) last announced its quarterly earnings data on Wednesday, February 28th. The company reported $0.06 earnings per share for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.07). DocGo had a net margin of 1.10% and a return on equity of 2.01%. The company had revenue of $199.25 million for the quarter, compared to analysts’ expectations of $195.48 million. As a group, research analysts anticipate that DocGo will post 0.35 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently commented on the stock. Needham & Company LLC reduced their price objective on shares of DocGo from $14.00 to $10.00 and set a “buy” rating for the company in a research note on Thursday, February 29th. Canaccord Genuity Group reduced their price objective on shares of DocGo from $10.00 to $9.00 and set a “buy” rating for the company in a research note on Thursday, April 11th. BTIG Research reduced their price objective on shares of DocGo from $13.00 to $11.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Stifel Nicolaus reduced their price objective on shares of DocGo from $11.00 to $8.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Finally, Cantor Fitzgerald reduced their price target on DocGo from $13.00 to $11.00 and set an “overweight” rating on the stock in a research report on Thursday, February 29th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, DocGo presently has a consensus rating of “Buy” and a consensus price target of $10.83.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.